pancrelipase

Also found in: Medical, Encyclopedia, Wikipedia.
Translations

pancrelipase

n pancrelipasa
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive
Similar mixture of enzymes is available as pancrelipase, which comprises more active lipase enzyme than pancreatin.
Pancreatin Market To Witness Swift Growth Owing To The Rise In Need To Treat Digestive Problems And Intestinal Gas Till 2022 / Million Insights
In May 2019, VIVUS announced a partnership to facilitate access to PANCREAZE (pancrelipase) Delayed Release Capsules for uninsured or underinsured patients with exocrine pancreatic insufficiency (EPI) that meet applicable eligibility criteria.
VIVUS Reports Second Quarter 2019 Financial Results
Eighty-eight patients with inoperable pancreatic cancer were randomly assigned to receive, in open-label fashion, pancreatic enzymes (pancrelipase; 48,000 lipase units per meal) or no pancreatic enzymes (control group).
Literature Review & Commentary
Exocrine pancreatic insufficiency (EPI) is treated with a pancreatic enzyme replacement such as pancrelipase. Pancrelipase helps break down fats (lipase), proteins (protease), and carbohydrates (amylase) to improve a patient's digestive system when the pancreas is no longer working properly due to pancreatic insufficiency.
Understanding the Clinical Significance of Serum Amylase and Lipase in the Digestive System
Approved in 2010, PANCREAZE is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes, including porcine-derived lipases, proteases and amylases.
VIVUS closes acquisition of PANCREAZE, financing transaction
M2 EQUITYBITES-May 2, 2016-Allergan announces positive opinion for the marketing authorisation of ENZEPI (pancrelipase) for exocrine pancreatic insufficiency (EPI) in the EU
Allergan announces positive opinion for the marketing authorisation of ENZEPI (pancrelipase) for exocrine pancreatic insufficiency (EPI) in the EU
M2 PHARMA-May 2, 2016-Allergan announces positive opinion for the marketing authorisation of ENZEPI (pancrelipase) for exocrine pancreatic insufficiency (EPI) in the EU
Allergan announces positive opinion for the marketing authorisation of ENZEPI (pancrelipase) for exocrine pancreatic insufficiency (EPI) in the EU
Pancrelipase is the generic name of all six PERT medications approved by the U.S.
Digestive enzyme replacement therapy: pancreatic enzymes and lactase
Studies evaluating this method used the pancrelipase with sodium bicarbonate to reach optimal pH (Dandeles, 2007).
Nurse led transgastric jejeunal feeding tube change under radiological guidance process of change
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.